EE9900566A - Vaccine compositions containing Helicobacter pylori FlgE polypeptide - Google Patents
Vaccine compositions containing Helicobacter pylori FlgE polypeptideInfo
- Publication number
- EE9900566A EE9900566A EEP199900566A EEP9900566A EE9900566A EE 9900566 A EE9900566 A EE 9900566A EE P199900566 A EEP199900566 A EE P199900566A EE P9900566 A EEP9900566 A EE P9900566A EE 9900566 A EE9900566 A EE 9900566A
- Authority
- EE
- Estonia
- Prior art keywords
- compositions containing
- helicobacter pylori
- vaccine compositions
- containing helicobacter
- flge polypeptide
- Prior art date
Links
- 241000590002 Helicobacter pylori Species 0.000 title 1
- 229940037467 helicobacter pylori Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56922—Campylobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702242A SE9702242D0 (en) | 1997-06-12 | 1997-06-12 | Vaccine compositions V |
| PCT/SE1998/001093 WO1998056816A1 (en) | 1997-06-12 | 1998-06-08 | VACCINE COMPOSITIONS COMPRISING THE HELICOBACTER PYLORI FlgE POLYPEPTIDE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9900566A true EE9900566A (en) | 2000-06-15 |
Family
ID=20407351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP199900566A EE9900566A (en) | 1997-06-12 | 1998-06-08 | Vaccine compositions containing Helicobacter pylori FlgE polypeptide |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1009764A1 (en) |
| JP (1) | JP2002507118A (en) |
| KR (1) | KR20010013699A (en) |
| CN (1) | CN1259960A (en) |
| AR (1) | AR012896A1 (en) |
| AU (1) | AU8048798A (en) |
| BR (1) | BR9810026A (en) |
| CA (1) | CA2293293A1 (en) |
| EE (1) | EE9900566A (en) |
| HU (1) | HUP0003164A3 (en) |
| ID (1) | ID23052A (en) |
| IL (1) | IL133144A0 (en) |
| IS (1) | IS5288A (en) |
| NO (1) | NO996132L (en) |
| NZ (1) | NZ501427A (en) |
| PL (1) | PL337503A1 (en) |
| SE (1) | SE9702242D0 (en) |
| SK (1) | SK173099A3 (en) |
| TR (1) | TR199903060T2 (en) |
| WO (1) | WO1998056816A1 (en) |
| ZA (1) | ZA984696B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104784687A (en) * | 2015-04-27 | 2015-07-22 | 苏州大学附属第一医院 | Application of flagellar hook protein FlgE of reorganized pseudomonas aeruginosa |
| CN113425717B (en) * | 2021-04-22 | 2023-06-16 | 成都欧林生物科技股份有限公司 | Medicament for improving efficacy of oral helicobacter pylori vaccine and application thereof |
| CN116535472B (en) * | 2023-05-31 | 2024-04-30 | 四川大学华西医院 | Helicobacter pylori recombinant protein antigen FlgK and preparation method and application thereof |
| CN118105473A (en) * | 2024-04-30 | 2024-05-31 | 成都欧林生物科技股份有限公司 | Oral immunogenic composition for preventing or treating Hp infection and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5459041A (en) * | 1988-02-18 | 1995-10-17 | Enteric Research Laboratories, Inc. | Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection |
| AR003125A1 (en) * | 1995-06-01 | 1998-07-08 | Astra Ab | BACTERIAL ANTIGENS FOR THE DIAGNOSIS OF INFECTIONS WITH HELICOBACTER PYLORI, A DNA MOLECLE THAT CODES IT, A VECTOR, A HOST CELL, A PROCEDURE FOR PRODUCING THE POLIPEPTIDE, USE OF ELEPIPETICO, AND PROAPILY USE |
-
1997
- 1997-06-12 SE SE9702242A patent/SE9702242D0/en unknown
-
1998
- 1998-06-01 ZA ZA984696A patent/ZA984696B/en unknown
- 1998-06-01 AR ARP980102558A patent/AR012896A1/en unknown
- 1998-06-08 CA CA002293293A patent/CA2293293A1/en not_active Abandoned
- 1998-06-08 PL PL98337503A patent/PL337503A1/en unknown
- 1998-06-08 TR TR1999/03060T patent/TR199903060T2/en unknown
- 1998-06-08 JP JP50228399A patent/JP2002507118A/en active Pending
- 1998-06-08 EE EEP199900566A patent/EE9900566A/en unknown
- 1998-06-08 AU AU80487/98A patent/AU8048798A/en not_active Abandoned
- 1998-06-08 NZ NZ501427A patent/NZ501427A/en unknown
- 1998-06-08 BR BR9810026-2A patent/BR9810026A/en not_active IP Right Cessation
- 1998-06-08 ID IDW991542A patent/ID23052A/en unknown
- 1998-06-08 WO PCT/SE1998/001093 patent/WO1998056816A1/en not_active Application Discontinuation
- 1998-06-08 IL IL13314498A patent/IL133144A0/en unknown
- 1998-06-08 SK SK1730-99A patent/SK173099A3/en unknown
- 1998-06-08 EP EP98928772A patent/EP1009764A1/en not_active Withdrawn
- 1998-06-08 KR KR1019997011714A patent/KR20010013699A/en not_active Application Discontinuation
- 1998-06-08 CN CN98806101A patent/CN1259960A/en active Pending
- 1998-06-08 HU HU0003164A patent/HUP0003164A3/en unknown
-
1999
- 1999-12-08 IS IS5288A patent/IS5288A/en unknown
- 1999-12-10 NO NO996132A patent/NO996132L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SK173099A3 (en) | 2000-06-12 |
| BR9810026A (en) | 2000-09-19 |
| AU8048798A (en) | 1998-12-30 |
| KR20010013699A (en) | 2001-02-26 |
| HUP0003164A2 (en) | 2000-12-28 |
| EP1009764A1 (en) | 2000-06-21 |
| AR012896A1 (en) | 2000-11-22 |
| CA2293293A1 (en) | 1998-12-17 |
| WO1998056816A1 (en) | 1998-12-17 |
| CN1259960A (en) | 2000-07-12 |
| JP2002507118A (en) | 2002-03-05 |
| NO996132D0 (en) | 1999-12-10 |
| TR199903060T2 (en) | 2000-09-21 |
| ID23052A (en) | 2000-01-20 |
| PL337503A1 (en) | 2000-08-28 |
| ZA984696B (en) | 1999-01-04 |
| SE9702242D0 (en) | 1997-06-12 |
| HUP0003164A3 (en) | 2001-10-29 |
| NO996132L (en) | 2000-01-28 |
| NZ501427A (en) | 2000-09-29 |
| IS5288A (en) | 1999-12-08 |
| IL133144A0 (en) | 2001-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE04481B1 (en) | A peptide and adjuvant based pharmaceutical composition for immune modulation | |
| IL142216A0 (en) | A polypeptide containing an immunogenic portion of a native wti and pharmaceutical compositions containing the same | |
| NO20001914D0 (en) | <alfa> -Aryl-N-alkylnitrons and pharmaceutical compositions containing them | |
| NO984881L (en) | Oral pharmaceutical surface preparation containing ibandronate | |
| NO996133D0 (en) | Oil-in-water vaccine formulations | |
| NO975490L (en) | Heliobacter pylori antigens and vaccine compositions | |
| NO995891L (en) | LH-RH peptide analogues, uses and pharmaceutical compositions containing them | |
| ID17860A (en) | VACCINE COMPOSITION | |
| DE69725482D1 (en) | Curable silicone compositions | |
| EP0998942A4 (en) | Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method | |
| EE9800334A (en) | Nucleic and amino acid sequences associated with Helicobacter pylor and vaccine compositions derived therefrom | |
| EE9800400A (en) | Pharmaceutical compositions containing diclofenac | |
| ID16781A (en) | PHARMACEUTICAL FORMULATIONS | |
| PT925273E (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 4-OXOBUTANOIC ACIDS | |
| BR9707657A (en) | Benzothiophene formulations containing the same and methods | |
| BR9708248A (en) | Benzothiophene formulations containing the same and methods | |
| AU1698699A (en) | (helicobacter pylori) vaccine formulations | |
| DE69804573T2 (en) | Organopolysiloxane compositions | |
| EE9900566A (en) | Vaccine compositions containing Helicobacter pylori FlgE polypeptide | |
| EE03511B1 (en) | Prolonged release pharmaceutical preparations containing misolastin | |
| ATE295182T1 (en) | COMPOSITIONS FOR IMMUNO-BOOSTING VACCINES | |
| NO981407D0 (en) | Protein from Helicobacter pylori | |
| AU8048698A (en) | Vaccine compositions comprising the (helicobacter pylori) pfr polypeptide | |
| AU7945798A (en) | Vaccine compositions comprising the (helicobacter pylori) 26kda polypeptide | |
| GB9413073D0 (en) | Helicobacter pylori vaccines/therapeutic compositions |